Glaxo says Advair shows edge over Spiriva in COPD
294238
GlaxoSmithKline Plc  said on  Friday that clinical trial results showed its top-seller Advair  had an edge over Pfizer Inc's  rival product Spiriva in  treating patients with the lung disease COPD.
525921
Bayer AG&#39;s  experimental pill  rivaroxaban is significantly more effective than standard  injections of Lovenox in preventing blood clots after knee  surgery, researchers said on Sunday.
508415
An early analysis from an ongoing study of GlaxoSmithKline Plc's Avandia was unable to show whether there was any increase in heart attacks among patients, but several experts said the evidence still suggested the popular diabetes drug raised the risk of heart attack.
364253
PARIS Sanofi-Aventis shares rose Monday after the French-German drugmaker reported a clinical study showing its experimental anti-obesity drug succeeded in helping people lose weight.
102028
Sanofi-Aventis  posted higher than expected fourth-quarter profits on Tuesday and predicted more growth for 2007, but a further delay in its key new anti-obesity drug Acomplia hit the shares.
459566
LONDON/NEW YORK  - A court ruling upholding the patent on blockbuster blood-thinning drug Plavix has reignited talk France's Sanofi-Aventis  will bid for its smaller U.S. partner Bristol-Myers Squibb Co. .
477879
The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its beleaguered chief rival Avandia, a new analysis shows. However, it also carries an increased risk of nonfatal heart failure, the analysis showed, confirming earlier studies.
310266
Trial results for a drug that controls bleeding include a favorable comparison with a similar product.
372654
GlaxoSmithKline yesterday trumpeted the preliminary results from a study it said found its embattled diabetes drug, Avandia , causes no more heart risks than other medications typically used by patients with diabetes .
542334
Galvus, a diabetes drug produced by Novartis, has received a positive opinion from European health authorities after the firm made changes to prescribing recommendations due to liver safety issues.
440218
Pfizer Inc. on Wednesday defended  its arthritis drug Bextra after a prominent cardiologist said a  pooled analysis of clinical trial results showed patients  taking the drug were twice as likely to have a heart attack or  stroke as those taking a placebo.
70027
A GlaxoSmithKline  blood pressure  medicine proved significantly better in keeping blood sugar  levels from rising in diabetics than another widely used member  of the beta blocker family of hypertension drugs, according to  a large clinical trial.
95372
Sanofi-Aventis posted higher than  expected fourth-quarter profits on Tuesday and predicted more  growth for 2007, but a further delay in its key new  anti-obesity drug Acomplia hit the shares.
768602
Shares of Sanofi-Aventis SA, the world&#39;s third biggest drugmaker, may rise after research presented at Europe&#39;s largest medical meeting showed two of the company&#39;s new drugs may benefit heart patients.
522802
CHICAGO -- The widely used diabetes pill Actos appears to lower a patient's chances of death, heart attack or stroke, unlike its chief competitor, Avandia, a new analysis shows.
84533
Pfizer Inc. PFE.N on Friday said two  clinical trials showed patients taking its anti-inflammatory  drug Bextra had a higher risk of cardiovascular events during  high-risk coronary bypass surgery.
237438
A Takeda Pharmaceuticals diabetes  drug was more effective in dealing with patients' cholesterol  problems than one made by GlaxoSmithKline in a head-to-head  study presented on Wednesday.